Commonwealth Equity Services’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,637
| Closed | -$35 | – | 3839 |
|
|
2023
Q1 | $35 | Buy |
15,637
+159
| +1% | – | ﹤0.01% | 3615 |
|
|
2022
Q4 | $58K | Buy |
15,478
+5,000
| +48% | +$18.7K | ﹤0.01% | 3499 |
|
|
2022
Q3 | $38K | Buy |
10,478
+4,993
| +91% | +$18.1K | ﹤0.01% | 3512 |
|
|
2022
Q2 | $75K | Sell |
5,485
-4
| -0.1% | -$55 | ﹤0.01% | 3418 |
|
|
2022
Q1 | $118K | Buy |
5,489
+100
| +2% | +$2.15K | ﹤0.01% | 3448 |
|
|
2021
Q4 | $145K | Buy |
5,389
+3
| +0.1% | +$81 | ﹤0.01% | 3378 |
|
|
2021
Q3 | $310K | Buy |
5,386
+2,496
| +86% | +$144K | ﹤0.01% | 2884 |
|
|
2021
Q2 | $289K | Buy |
2,890
+560
| +24% | +$56K | ﹤0.01% | 2934 |
|
|
2021
Q1 | $354K | Buy |
2,330
+1,095
| +89% | +$166K | ﹤0.01% | 2618 |
|
|
2020
Q4 | $147K | Buy |
1,235
+497
| +67% | +$59.2K | ﹤0.01% | 2994 |
|
|
2020
Q3 | $175K | Buy |
738
+303
| +70% | +$71.9K | ﹤0.01% | 2768 |
|
|
2020
Q2 | $123K | Buy |
435
+299
| +220% | +$84.5K | ﹤0.01% | 2738 |
|
|
2020
Q1 | $40K | Buy |
+136
| New | +$40K | ﹤0.01% | 2706 |
|